Provided by Tiger Fintech (Singapore) Pte. Ltd.

Greenwich Lifesciences Inc

9.52
-0.1246-1.29%
Volume:12.87K
Turnover:123.35K
Market Cap:127.20M
PE:-7.52
High:9.76
Open:9.68
Low:9.48
Close:9.64
Loading ...

Greenwich Lifesciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
24 May

Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
22 May

Greenwich LifeSciences Q1 EPS $(0.25) Down From $(0.19) YoY

Benzinga
·
21 May

Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
17 May

Greenwich Lifesciences Inc. Delays Quarterly Financial Report, Filing Expected by May 20

Reuters
·
16 May

Top Executive Makes Bold Investment in Greenwich LifeSciences!

TIPRANKS
·
30 Apr

Greenwich LifeSciences CEO Makes Bold Stock Purchase!

TIPRANKS
·
23 Apr

Greenwich LifeSciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
21 Apr

Greenwich Lifesciences, Inc. : H.c. Wainwright Raises Target Price to $39 From $38

THOMSON REUTERS
·
21 Apr

Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
12 Apr

Greenwich LifeSciences CEO Makes Bold Stock Purchase!

TIPRANKS
·
09 Apr

BRIEF-Greenwich Lifesciences Provides Global Update On Flamingo-01

Reuters
·
03 Apr

Greenwich LifeSciences provides global update on FLAMINGO-01

TIPRANKS
·
03 Apr

Greenwich Lifesciences Provides Global Update on Flamingo-01

THOMSON REUTERS
·
03 Apr

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

GlobeNewswire
·
03 Apr

BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group

Reuters
·
03 Apr

Greenwich Lifesciences Shares up 9% After Late-Stage Trial Data for Breast Cancer Therapy

THOMSON REUTERS
·
02 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Greenwich, CoreWeave, Blackberry

Reuters
·
02 Apr

BUZZ-Greenwich rises on immune response data from breast cancer therapy trial

Reuters
·
02 Apr

BRIEF-Greenwich Lifesciences Announces Positive Immune Response Data From FLAMINGO-01 Phase III Clinical Trial

Reuters
·
02 Apr